JVLAX
Price
$26.21
Change
-$0.09 (-0.34%)
Updated
Sep 5 closing price
Net Assets
18.33B
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

JVLAX vs VVIAX

Header iconJVLAX vs VVIAX Comparison
Open Charts JVLAX vs VVIAXBanner chart's image
JHancock Disciplined Value A
Price$26.21
Change-$0.09 (-0.34%)
VolumeN/A
Net Assets18.33B
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
JVLAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVLAX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVLAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. JVLAX (18.3B). VVIAX pays higher dividends than JVLAX: VVIAX (2.10) vs JVLAX (0.66). JVLAX was incepted earlier than VVIAX: JVLAX (17 years) vs VVIAX (25 years). JVLAX (0.97) is less costly to investors than VVIAX (0.05). JVLAX is a more actively managed with annual turnover of: 63.00 vs. VVIAX (9.00). JVLAX has a lower initial minimum investment than VVIAX: JVLAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. JVLAX (1.31). VVIAX return over 5 years is better than : 70.16 vs. JVLAX (42.07).
JVLAXVVIAXJVLAX / VVIAX
Total Expense Ratio0.960.051,920%
Annual Report Gross Expense Ratio0.970.051,940%
Fund Existence17 years25 years-
Gain YTD10.6847.850136%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets18.3B203B9%
Annual Yield % from dividends0.662.1031%
Returns for 1 year1.317.7417%
Returns for 3 years19.5936.6154%
Returns for 5 years42.0770.1660%
Returns for 10 years49.37131.6138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity